Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: Results of the HOMe ALONE study
Clinical Kidney Journal Nov 01, 2021
Emrich IE, Scheuer AL, Rogacev KS, et al. - Plasma biomarkers can strongly and independently predict the occurrence of heart failure and atherosclerotic cardiovascular events post-kidney transplantation, whereas standard echocardiographic follow-up does not enhance cardiovascular risk prediction.
Kidney transplant recipients (KTRs) carry a high cardiovascular disease burden.
A prospective study (HOMe ALONE) of 177 KTR who were followed-up for 5.4 ± 1.7 years.
A consistent association of only NT-proBNP (among all echocardiographic and plasma biomarkers measured) with hospitalization for acute decompensated heart failure or all-cause death was evident (third vs first tertile: HR 4.20).
Only troponin T was consistently related to major atherosclerotic cardiovascular events or all-cause death (third vs first tertile: HR 8.15).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries